Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.
Krishnan J, Patel A, Roy AM, Alharbi M, Kapoor A, Yao S, Khoury T, Hong CC, Held N, Chakraborty A, Kaliniski P, Salman A, Catalfamo K, Attwood K, Kirtani V, Shaikh SS, Chaudhary LN, Gandhi S.
Krishnan J, et al. Among authors: hong cc.
Clin Breast Cancer. 2024 Dec;24(8):e701-e711.e2. doi: 10.1016/j.clbc.2024.08.005. Epub 2024 Aug 6.
Clin Breast Cancer. 2024.
PMID: 39198116
Free article.